08/08/2024 6:47 AM | Vanda Pharmaceuticals (Filer)
| Form 8-A12B/A | |
08/08/2024 6:29 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 6:01 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024 3:05 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/29/2024 4:21 PM | Moran Kevin Patrick (Reporting) Vanda Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024 4:24 PM | Moran Kevin Patrick (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:38 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
06/06/2024 3:30 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 3:43 PM | Chrousos Phaedra (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 3:49 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 3:52 PM | Vanda Pharmaceuticals (Issuer) Ward Anne Sempowski (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:53 PM | Mitchell Stephen Ray (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:53 PM | DUGAN RICHARD W (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:55 PM | Honore Tage (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:34 PM | Vanda Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/20/2024 4:26 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 4:15 PM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
05/09/2024 6:07 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024 3:51 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 5:17 AM | Vanda Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2024 5:26 AM | Vanda Pharmaceuticals (Filer)
| Form ARS | |
04/17/2024 4:26 PM | Vanda Pharmaceuticals (Filer)
| Form 8-A12B | |
04/17/2024 4:19 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2024 3:32 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2024 3:31 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 3:48 PM | Vanda Pharmaceuticals (Issuer) Wijkstrom Joakim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:50 PM | Vanda Pharmaceuticals (Issuer) Williams Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 8:06 PM | Birznieks Gunther (Reporting) Vanda Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 8:08 PM | Moran Kevin Patrick (Reporting) Vanda Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 8:10 PM | Polymeropoulos Mihael Hristos (Reporting) Vanda Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 8:12 PM | Vanda Pharmaceuticals (Subject) Wijkstrom Joakim (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 8:14 PM | Vanda Pharmaceuticals (Subject) Williams Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 3:50 PM | Birznieks Gunther (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:52 PM | Polymeropoulos Mihael Hristos (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:52 PM | Moran Kevin Patrick (Reporting) Vanda Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:52 PM | Vanda Pharmaceuticals (Issuer) Wijkstrom Joakim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:53 PM | Vanda Pharmaceuticals (Issuer) Williams Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:31 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K/A | |
02/13/2024 9:53 AM | RENAISSANCE TECHNOLOGIES LLC (Filed by) Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 6:19 AM | Vanda Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/05/2024 3:34 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Why billionaires are wiring money to abandoned towns (Ad) A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. ![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9254&Placement=NativeDisplay&Source=NativeDisplay) Click here for my exclusive video |
01/23/2024 10:52 AM | BlackRock Inc. (Filed by) Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/22/2024 10:26 AM | STATE STREET CORP (Filed by) Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/07/2023 4:19 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:04 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/06/2023 1:34 PM | BlackRock Inc. (Filed by) Vanda Pharmaceuticals (Subject)
| Form SC 13G/A | |